Clinical Trials Browser

Phase 3 × Completed × Duloxetine Hydrochloride × Clear all

NCT01598298 2022-12-16

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

Phase 3 Completed

299 enrolled 10 charts

Breast Neoplasms, Pain

NCT00489411 2017-04-26

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Phase 3 Completed

231 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes